Clinical Trial Update: DES Versus BiOSS LIM - POLBOS II Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing drug-eluting stents (DES) versus BiOSS LIM stent in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BiOSS LIM stent
• Drug-Eluting Stent (DES) (drug-eluting stent)

Snippet

Sponsor: Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED